No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
USPH240517P120000
- 18.00
- 0.000.00%
15min DelayClose May 8 15:52 ET
18.00High18.00Low
18.00Open18.00Pre Close1 Volume1 Open Interest120.00Strike Price1.80KTurnover53.85%IV-0.07%PremiumMay 17, 2024Expiry Date16.08Intrinsic Value100Multiplier8DDays to Expiry1.92Time Value100Contract SizeAmericanOptions Type-0.9608Delta0.0129Gamma6.43Leverage Ratio-0.0299Theta-0.0127Rho-6.18Eff Leverage0.0132Vega
Intraday
- 5D
- 1D
News
Buy Rating for US Physical Therapy: Strong Performance and Positive Growth Outlook
Q1 2024 US Physical Therapy Inc Earnings Call
US Physical Therapy Inc (USPH) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...
US Physical Therapy | 10-Q: Quarterly report
U.S. Physical Therapy, Inc. (USPH) Q1 2024 Earnings Call Transcript
U.S. Physical Therapy, Inc. (USPH) Q1 2024 Earnings Call Transcript
Express News | U.S. Physical Therapy Sees 2024 Adj. EBITDA $82.5M-$87.5M
Comments
U.S. Physical Therapy's declining ROCE trend is concerning. Despite reinvestment, returns are shrinking and shareholder returns have been flat over five years. The stock doesn't show multi-bagger traits, suggesting investors may find better options elsewhere.
Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal 1
Investors remain optimistic about U.S. Physical Therapy's robust earnings outlook. The market's high P/E ratio reflects strong future growth expectations for the company, despite the industry average.
The cautious investor sentiment towards the company's future is reflected in declining share price and EPS. A potential stabilization is indicated by a 0.7% TSR gain over past year, albeit below market return.
Read more